Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Maria Douvali"'
Autor:
Irini Chatziralli, George Theodossiadis, Maria Douvali, Alexandros A. Rouvas, Panagiotis Theodossiadis
Publikováno v:
Case Reports in Ophthalmology, Vol 8, Iss 1, Pp 116-119 (2017)
Introduction: Postoperative eccentric macular hole (MH) formation is an uncommon complication after pars plana vitrectomy (PPV) with internal limiting membrane (ILM) peeling for epiretinal membrane or MH treatment. Herein, we present a case of eccent
Externí odkaz:
https://doaj.org/article/a1c854b080c844ecba0000561fbd4ed5
Autor:
Maria Douvali, Alexandros Rouvas, Maria Theodorou, Georgios Koutsocheras, Panagiotis Theodossiadis, Nikolaos Bouratzis, Nikolaos Gouliopoulos, Panagiota Bougatsou
Publikováno v:
European Journal of Ophthalmology. 31:2868-2875
Purpose: To compare the 1-year outcomes of treat-and-extend and pro re nata (PRN) treatment regimens with aflibercept for polypoidal choroidal vasculopathy (PCV), by the means of visual acuity (VA), frequency of recurrence of polypoidal lesions and d
Autor:
George Theodossiadis, Maria Douvali, Panagiotis Theodossiadis, Alexandros Rouvas, Irini Chatziralli
Publikováno v:
Case Reports in Ophthalmology, Vol 8, Iss 1, Pp 116-119 (2017)
Case Reports in Ophthalmology
Case Reports in Ophthalmology
Introduction: Postoperative eccentric macular hole (MH) formation is an uncommon complication after pars plana vitrectomy (PPV) with internal limiting membrane (ILM) peeling for epiretinal membrane or MH treatment. Herein, we present a case of eccent
Autor:
Irini Chatziralli, Stamatina A. Kabanarou, Alexandros Rouvas, Dimitrios Alonistiotis, Panagiota Mpougatsou, Panagiotis Theodossiadis, Maria Douvali, Angeliki Androu
Publikováno v:
International ophthalmology. 39(2)
To compare the efficacy and safety of two intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents, ranibizumab and aflibercept, for the treatment of vascularized pigment epithelium detachment (vPED) due to age-related macular degenera
Autor:
Irini Chatziralli, Alexandros Rouvas, Klio Chatzistefanou, Emmanouella Giannakaki, Maria Douvali, Panagiotis Theodossiadis
Publikováno v:
Ophthalmologica. 232:136-143
Purpose: To evaluate the impact of macular ischemia on the functional and anatomical outcome after intravitreal injections of ranibizumab for the treatment of diabetic macular edema (DME). Procedures: Participants were 49 patients with diabetes melli
Autor:
Alexandros Rouvas, Ioannis Ladas, Irini Chatziralli, Athanasios I. Kotsolis, Maria Douvali, Ilias Georgalas, Panagiotis Theodossiadis
Publikováno v:
Ophthalmologica. 228:93-101
Background: To compare the efficacy of thermal laser photocoagulation versus intravitreal ranibizumab for the treatment of extrafoveal classic choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD). Methods: We conduct
Autor:
Alexandros Rouvas, Thanos D. Papakostas, Maria Douvali, Amalia Ntouraki, Ioannis Ladas, Ioannis Vergados
Publikováno v:
Retina. 31:464-474
The purpose of this study was to compare photodynamic therapy (PDT), ranibizumab, and ranibizumab with PDT in polypoidal choroidal vasculopathy.In this retrospective comparative study, 30 eyes of 30 patients with polypoidal choroidal vasculopathy wer
Publikováno v:
Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde. 233(2)
Autor:
Panagiotis Theodossiadis, Vasilios S. Liarakos, Maria Douvali, Dimitrios Papaconstantinou, Ioannis Vergados
Publikováno v:
European journal of ophthalmology. 24(3)
PURPOSE To evaluate the effect of subconjunctival anti-vascular endothelial growth factor (VEGF) ranibizumab on corneal and anterior segment neovascularization. METHODS In this experimental study and laboratory investigation, chemical cauterization w
Autor:
Nikolaos Markomichelakis, Petros Petrou, Ilias Georgalas, Maria Douvali, Amalia Ntouraki, Ioannis Vergados, Alexander Rouvas
Publikováno v:
Retina (Philadelphia, Pa.). 31(5)
PURPOSE To evaluate the effect of individualized repeated intravitreal injections of ranibizumab (Lucentis) on visual acuity and central foveal thickness in patients with choroidal neovascular membrane (CNV) associated with various ocular inflammator